MOLECULAR ASPECTS OF MEDICINE
Scope & Guideline
Transforming Insights into Molecular Health Solutions
Introduction
Aims and Scopes
- Molecular Mechanisms in Disease Pathogenesis:
The journal explores the underlying molecular mechanisms that contribute to various diseases, including cancer, metabolic disorders, and autoimmune diseases. This focus helps elucidate the biological processes that lead to disease onset and progression. - Therapeutic Innovations and Drug Development:
A significant aim is to present advancements in therapeutic strategies, including novel drug candidates, vaccine development, and innovative treatment modalities. This includes research on gene therapy, immunotherapy, and nanotechnology applications in medicine. - Impact of Aging and Age-Related Disorders:
Research on aging, sarcopenia, and age-related diseases is prominently featured, addressing the molecular aspects of how aging affects health and contributes to various pathologies, thereby informing preventive and therapeutic approaches. - Role of the Immune System in Health and Disease:
The journal emphasizes the importance of immunology in understanding disease mechanisms and developing therapies. This includes studies on immune modulation, the impact of immune responses on various diseases, and the development of immune-based therapies. - Biomarkers and Diagnostic Advances:
An additional focus is on the identification and validation of biomarkers for disease diagnosis and prognosis, along with advancements in molecular diagnostics that enhance clinical decision-making.
Trending and Emerging
- Cancer Immunotherapy and Vaccination:
An increasing number of articles focus on immunotherapy and vaccine development for cancer, reflecting a significant trend in oncology towards harnessing the immune system to combat malignancies. - Understanding the Microbiome's Role in Health:
Research exploring the human microbiome, particularly its impact on various diseases and therapeutic potentials, has gained traction, indicating a shift towards integrating microbiome studies into mainstream medical research. - Aging and Geroscience:
There is a notable rise in research focused on aging, frailty, and age-related diseases, emphasizing the need for interventions that address the molecular underpinnings of aging and promote healthy longevity. - Advancements in Molecular Diagnostics and Biomarkers:
The journal increasingly features studies on cutting-edge diagnostic technologies and biomarker discovery, highlighting the importance of precision medicine and personalized approaches in healthcare. - Extracellular Vesicles in Disease Mechanisms:
Research on extracellular vesicles and their roles in intercellular communication, diagnostics, and therapeutics is emerging as a significant theme, reflecting advancements in understanding cellular interactions and disease pathology.
Declining or Waning
- Traditional Drug Discovery Approaches:
There seems to be a waning interest in classical drug discovery methodologies, as the journal increasingly emphasizes innovative approaches such as personalized medicine and targeted therapies. - Generalized Studies on Nutritional Aspects:
While nutrition remains important, there has been a noticeable decline in papers focusing on broad nutritional studies, as the journal pivots towards more specific molecular interactions and mechanisms linking diet to health outcomes. - Basic Mechanistic Studies without Clinical Relevance:
Research that focuses solely on basic molecular mechanisms without clear clinical implications appears to be decreasing, suggesting a shift towards studies that directly inform therapeutic applications and patient outcomes.
Similar Journals
Molecular Therapy Oncolytics
Advancing Oncological Science for Global ImpactMolecular Therapy Oncolytics is an esteemed Open Access journal published by CELL PRESS, focusing on cutting-edge research in the fields of oncology, molecular medicine, and pharmacology. Established in 2014, the journal has quickly gained a prominent position in the academic community, reflected in its impressive Q1 and Q2 rankings across various categories including Cancer Research, Molecular Medicine, and Pharmacology. With an impactful presence in the UK and a strong international readership, it aims to disseminate significant advancements in therapeutic strategies targeted at cancer treatment and management. By providing a platform for peer-reviewed research, Molecular Therapy Oncolytics plays a critical role in bridging the gap between scientific innovation and clinical application, making it an invaluable resource for researchers, healthcare professionals, and students striving to contribute to the evolving landscape of oncology.
EXPERT REVIEWS IN MOLECULAR MEDICINE
Cutting-edge Reviews from Leading ExpertsEXPERT REVIEWS IN MOLECULAR MEDICINE, published by Cambridge University Press, stands at the forefront of research in the fields of Molecular Biology and Molecular Medicine. With an impressive impact factor reflecting its Q1 status in both relevant categories, this journal serves as an essential platform for disseminating cutting-edge reviews and critical assessments that are vital for advancing our understanding of molecular mechanisms in health and disease. Established in 1997 and continuously evolving until 2024, it features contributions from leading experts that highlight emerging trends and innovative methodologies. Researchers, professionals, and students are encouraged to engage with the content, benefiting from the journal’s rigorous peer-review process and its commitment to academic excellence, making it a valuable resource within the scientific community.
Aging-US
Transforming Insights into Aging and HealthAging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Innovating diagnostics through experimental insights.EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.
MOLECULAR AND CELLULAR BIOLOGY
Driving Innovation in Molecular and Cellular ScienceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
Journal of Biomedical Research
Uncovering Breakthroughs in Health and DiseaseJournal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.
JOURNAL OF BIOMEDICAL SCIENCE
Connecting researchers to shape the future of biomedicine.JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.
JOURNAL OF MOLECULAR MEDICINE-JMM
Championing High-Quality Research in Biomedical Science.JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.
Advanced Biology
Unlocking the Secrets of Life at the Molecular LevelAdvanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.
Cold Spring Harbor Perspectives in Medicine
Fostering Dialogue for a Healthier TomorrowCold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.